Colorectal cancer chemotherapy: irinotecan
Rougier, P.; Mitry, E.
Seminars in Oncology 27(5 Suppl. 10): 138-143
2000
ISSN/ISBN: 0093-7754 PMID: 11049046 Document Number: 524244
Document emailed within 1 workday
Related Documents
Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954Li, J.; Xu, J-Ming.; Li, J.; Zhang, X-Dong.; Bai, Y.; Chu, Y-Ping.; Wang, Y-Hua.; Liu, D-Qi.; Jin, M-Lin.; Shen, L. 2008: Irinotecan plus fuorouracil/leucovorin (FOLFIRI) as a second line chemotherapy for refractory or metastatic colorectal cancer Zhonghua Zhong Liu Za Zhi 30(3): 225-227
Motoori, S.; Hosokawa, Y.; Miyazawa, T.; Iwamoto, N.; Kase, Y.; Kitagawa, N.; Saisho, H.; Furuse, J. 2010: Two cases of colorectal cancer presenting with periodic, transient elevation of serum iron after chemotherapy including irinotecan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(11): 2185-2188
Shitara, K.; Munakata, M.; Kudo, T.; Kasai, M.; Muto, O.; Okada, R.; Mitobe, S.; Ishiguro, A.; Sakuraba, H.; Ikami, I.; Sakata, Y. 2006: Combination chemotherapy with hepatic arterial infusion of 5-fluorouracil (5-FU) and systemic irinotecan (CPT-11) in patients with unresectable liver metastases from colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(13): 2033-2037
Adam, R. 2004: Resection of liver metastasis of colorectal origin following chemotherapy with irinotecan Annales de Chirurgie 129 Spec no 2: 2-4
Ratanatharathorn, V.; Sirachainan, E.; Jirajarus, M.; Sirilerttrakul, S. 2000: Clinical activity and benefit of irinotecan (CPT-11) in patients with metastatic colorectal carcinoma pre-treated with fluorouracil-based chemotherapy Journal of the Medical Association of Thailand 83(10): 1187-1195
Govindarajan, R. 2000: Irinotecan and thalidomide in metastatic colorectal cancer Oncology 14(12 Suppl. 13): 29-32
See, H.T.; Koo, W.H.; Ang, P.; Au, E.; Ang, P.T. 2002: Efficacy and tolerability of irinotecan in patients with advanced colorectal cancer in Singapore Annals of the Academy of Medicine Singapore 31(5): 651-655
Zhou, Z-Tao.; Wang, J-Wan. 2006: Present status and prospect of irinotecan application in adjuvant therapy for colorectal cancer Zhonghua Zhong Liu Za Zhi 28(7): 553-554
Mishima, H.; Ikenaga, M.; Ishida, H.; Iwamoto, S.; Morimoto, T.; Narahara, H.; Kato, T.; Tsujie, M.; Kitai, T.; Fukunaga, M.; Nakanishi, M.; Tsujinaka, T.; Furukawa, H.; Taguchi, T. 2007: Multicenter phase II study of irinotecan plus bolus fluorouracil/l-leucovorin for metastasic colorectal cancer Anticancer Research 27(2): 1003-1008
Hibi, S.; Ina, K.; Furuta, R.; Kataoka, T.; Kojima, S.; Kawai, M. 2009: Clinical effects of Hange-shashin-to on combination therapy of S-1/irinotecan against the for patients with metastatic gastric and colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(9): 1485-1488
Liang, X-Bo.; Hou, S-Huai.; Li, Y-Ping.; Wang, L-Chun.; Zhang, X.; Yang, J. 2010: Irinotecan or oxaliplatin combined with 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer: a meta-analysis Chinese Medical Journal 123(22): 3314-3318
Chitapanarux, I.; Tonusin, A.; Sukthomya, V.; Charuchinda, C.; Pukanhapan, N.; Lorvidhaya, V. 2003: Phase II clinical study of irinotecan and cisplatin as first-line chemotherapy in metastatic or recurrent cervical cancer Gynecologic Oncology 89(3): 402-407
Abou-Mourad, Y.; Otrock, Z.K.; Makarem, J.A.; Kattan, J.G.; Farhat, F.S.; Jalloul, R.; Mokaddem, W.T.; Ghosen, M.G.; Taher, A.T.; Chehal, A.A.; Shamseddine, A.I. 2008: Docetaxel and irinotecan as first-line chemotherapy in patients with advanced non-small-cell lung cancer: a pilot study Le Journal Medical Libanais. Lebanese Medical Journal 56(1): 16-21
Tanaka, K.; Kumamoto, T.; Nojiri, K.; Mori, R.; Matsuyama, R.; Takeda, K.; Ota, M.; Akiyama, H.; Ichikawa, Y.; Endo, I. 2010: Prehepatectomy chemotherapy using hepatic artery infusion plus systemic chemotherapy for liver metastases from colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(12): 2267-2270
Ueda, A.; Hosokawa, A.; Ogawa, K.; Yoshita, H.; Mihara, H.; Ando, T.; Kajiura, S.; Fujinami, H.; Nishikawa, J.; Minemura, M.; Terada, M.; Kobayashi, T.; Horikawa, N.; Yabushita, K.; Note, M.; Sugiyama, T. 2013: Non-randomized comparison between irinotecan plus mitomycin C and irinotecan alone in patients with advanced gastric cancer refractory to fluoropyrimidine and platinum Anticancer Research 33(11): 5107-5111
Lin, C.-P.; Chi, P. 2009: Clinical study of postoperative intraperitoneal chemotherapy combined with systemic chemotherapy for serosa-involved colorectal cancer Zhonghua Wei Chang Wai Ke Za Zhi 12(3): 257-260
Tanaka, H.; Umekawa, T.; Nagao, K.; Ishihara, A.; Toyoda, N. 2003: Salvage chemotherapy with a combination of irinotecan hydrochloride and mitomycin C in platinum- and paclitaxel-resistant epithelial ovarian cancer: case reports European Journal of Gynaecological Oncology 24(3-4): 337-340
Tanaka, A.; Aragane, N.; Komiya, K.; Kawaura, F.; Fukuno, Y.; Hayashi, S. 2008: A pilot study of irinotecan hydrochloride(CPT-11)and cisplatin(CDDP)combination chemotherapy for previously treated non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(1): 49-53
Hotta, T.; Takifuji, K.; Arii, K.; Yokoyama, S.; Matsuda, K.; Higashiguchi, T.; Tominaga, T.; Oku, Y.; Yamaue, H. 2006: Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival Anticancer Research 26(2b): 1425-1432